ArticleCureus2025

A Placebo-Controlled Exploratory Trial of Sirolimus for Tocilizumab-Resistant Idiopathic Multicentric Castleman Disease: Early Termination and Long-Term Extension Results Based on Descriptive Results From Two Patients.

Tomohiro Koga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.